Mapa de alterações epigenéticas do Bócio Coloide

Abstract

Introduction: The colloid goiter (CG) is a heterogeneous disorder and represents the main cause of benign thyroid nodule. Prevalent in geographical areas with iodine deficiency, in most cases carried out expectant conduct or surgically. Classified according to the morphological and functional characteristics, it may present as diffuse or nodular, toxic or nontoxic (with or without functional autonomy). Can reach large volume and compression of neck structures or even turn into malignant disease. Dependent on environmental and genetic factors, with iodine deficiency being the main determinant for the impact on incidence, other environmental and hereditary factors are listed, but little is known about the molecular pathogenesis. Objectives: To map the Epigenetic alterations of the five different surgical parts of CG from patients submitted to total thyroidectomy in Manaus, Amazonas, to analyze, compare and describe the specific pattern for this population. Methods: Five specimens of CG with histopathological confirmation were obtained from the “Normal Thyroid Tissue Bank and with Goiter” from the UFAM. Were used to identify the global methylation patterns of DNA and histone 3 in trimethylated lysine 4, 9 and 27 (H3K4me3, H3K9me3 and H3K27me3). Was used an ELISA type specific immunoassay method, with the results compared between the patients, between the different region of the gland in the same individual and between the individuals. Results: there was no evidence there were significant differences (5%) in the mean global DNA methylation patterns between the patients (p = 0.114) or between the thyroid regions (p = 0.843) considered similar. The mean pan-methylation patterns of histones H3K4me3, H3K9me3 and H3K27me3 are significantly different among patients (p <1%), although there were no significant differences between parts in the same individual (p> 5%). Conclusion: The results of the analyzes of this study revealed that CG parts obeyed a pattern of distribution of significant DNA hypermethylation between patients and parts of CG, differing only among patients the pattern of histone methylation. As these findings are more common in cancer, we may suggest that at the epigenetic level CG may have some common etiologic factor that leads to this tissue response or that responds by phenotypic expressions and malignant transformation. There are now no efficient markers that accurately detect the risk of CG malignancy, much less the possibility of defining its tissue progression, it is very likely that multiple genes will participate in this process. Therefore, the findings found in these patients may make way for the future application of the CG epigenetic study, which may imply the viability of new therapeutic or preventive forms of progression, since the methylation status can be reversed, but other studies in the population are needed to understand better those finding.